Osteoclastogenesis inhibition by mutated IGSF23 results in human osteopetrosis.
Ying YuanLi YangTing LiuHong ZhangQiong LuPublished in: Cell proliferation (2019)
IGSF23-mediated osteoclast differentiation of PBMCs may serve as a potential target in osteoporosis therapy.